Cargando…

Parenteral oestrogen in the treatment of prostate cancer: a systematic review

The objectives of this study were to assess the effectiveness and safety of parenteral oestrogen in the treatment of prostate cancer, and to examine any dose relationship. A systematic review was undertaken. Electronic databases, published paper and internet resources were searched to locate publish...

Descripción completa

Detalles Bibliográficos
Autores principales:	Norman, G, Dean, M E, Langley, R E, Hodges, Z C, Ritchie, G, Parmar, M K B, Sydes, M R, Abel, P, Eastwood, A J
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2008
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2259178/ https://www.ncbi.nlm.nih.gov/pubmed/18268497 http://dx.doi.org/10.1038/sj.bjc.6604230

Ejemplares similares

Mortality following development of breast cancer while using oestrogen or oestrogen plus progestin: a computer record-linkage study
por: Chen, W, et al.
Publicado: (2005)

CITED2 and NCOR2 in anti-oestrogen resistance and progression of breast cancer
por: van Agthoven, T, et al.
Publicado: (2009)

Clinical benefit from neoadjuvant chemotherapy in oestrogen receptor-positive invasive ductal and lobular carcinomas
por: Delpech, Y, et al.
Publicado: (2013)

A systematic review of the effectiveness of docetaxel and mitoxantrone for the treatment of metastatic hormone-refractory prostate cancer
por: Collins, R, et al.
Publicado: (2006)

Oestrogens and oestrogen receptors in prostate cancer
por: Kowalska, Karolina, et al.
Publicado: (2016)

Steroid sulphatase and oestrogen sulphotransferase in human non-small-cell lung carcinoma
por: Iida, S, et al.
Publicado: (2013)

Oestrogen receptor status, treatment and breast cancer prognosis in Icelandic BRCA2 mutation carriers
por: Jonasson, Jon G, et al.
Publicado: (2016)

Lack of association between oestrogen receptor polymorphisms and change in bone mineral density with tamoxifen therapy
por: Henry, N L, et al.
Publicado: (2010)

Increased pathological complete response rate after a long-term neoadjuvant letrozole treatment in postmenopausal oestrogen and/or progesterone receptor-positive breast cancer
por: Allevi, G, et al.
Publicado: (2013)

Exemestane as primary treatment of oestrogen receptor-positive breast cancer in postmenopausal women: a phase II trial
por: Barnadas, A, et al.
Publicado: (2009)

Comparative Efficacy of Three Forms of Parenteral Iron
por: Dillon, Richard, et al.
Publicado: (2012)

Clinical utility of the IHC4+C score in oestrogen receptor-positive early breast cancer: a prospective decision impact study
por: Yeo, B, et al.
Publicado: (2015)

Increased mortality in HER2 positive, oestrogen receptor positive invasive breast cancer: a population-based study
por: Purdie, C A, et al.
Publicado: (2010)

Patient-reported outcomes of parenteral somatostatin analogue injections in 195 patients with acromegaly
por: Strasburger, Christian J, et al.
Publicado: (2016)

Androgen receptor expression predicts beneficial tamoxifen response in oestrogen receptor-α-negative breast cancer
por: Hilborn, Erik, et al.
Publicado: (2016)

Postmenopausal breast cancer and oestrogen associations with the IgA-coated and IgA-noncoated faecal microbiota
por: Goedert, James J, et al.
Publicado: (2018)

Long-term clinical outcome of oestrogen receptor-positive operable primary breast cancer in older women: a large series from a single centre
por: Syed, B M, et al.
Publicado: (2011)

Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer
por: Heijnsdijk, E A M, et al.
Publicado: (2009)

Oestrogen receptor status, pathological complete response and prognosis in patients receiving neoadjuvant chemotherapy for early breast cancer
por: Ring, A E, et al.
Publicado: (2004)

Influence of Preoperative Peripheral Parenteral Nutrition with Micronutrients after Colorectal Cancer Patients
por: Liu, Ming-Yi, et al.
Publicado: (2015)

The Correlation between Diffusion-Weighted Imaging and Histopathological Evaluation of 356 Prostate Biopsy Sites in Patients with Prostatic Diseases
por: Kilinç, R., et al.
Publicado: (2012)

The impact of the 21-gene assay on adjuvant treatment decisions in oestrogen receptor-positive early breast cancer: a prospective study
por: Kuchel, Anna, et al.
Publicado: (2016)

Follow-up care for men with prostate cancer and the role of primary care: a systematic review of international guidelines
por: McIntosh, H M, et al.
Publicado: (2009)

Plasma phyto-oestrogens and prostate cancer in the European Prospective Investigation into Cancer and Nutrition
por: Travis, R C, et al.
Publicado: (2009)

Designing phase II trials in cancer: a systematic review and guidance
por: Brown, S R, et al.
Publicado: (2011)

Prognostic value of prostate circulating cells detection in prostate cancer patients: a prospective study
por: Eschwège, P, et al.
Publicado: (2009)

The role of oestrogen and progesterone receptors in gigantomastia
por: Kasielska-Trojan, Anna, et al.
Publicado: (2019)

Cardiovascular outcomes in patients with locally advanced and metastatic prostate cancer treated with luteinising-hormone-releasing-hormone agonists or transdermal oestrogen: the randomised, phase 2 MRC PATCH trial (PR09)
por: Langley, Ruth E, et al.
Publicado: (2013)

Clinical relevance of genetic instability in prostatic cells obtained by prostatic massage in early prostate cancer
por: Thuret, R, et al.
Publicado: (2005)

Quality of Life in the Management of Home Parenteral Nutrition
por: Schönenberger, Katja A., et al.
Publicado: (2023)

Anastrozole (‘Arimidex’) blocks oestrogen synthesis both peripherally and within the breast in postmenopausal women with large operable breast cancer
por: Miller, W R, et al.
Publicado: (2002)

Androgen receptor expression in circulating tumour cells from castration-resistant prostate cancer patients treated with novel endocrine agents
por: Crespo, M, et al.
Publicado: (2015)

Plasma oestrogens and oestrogen receptors in breast cancer patients.
por: Mason, R. C., et al.
Publicado: (1985)

Prognostic value of Ki-67 for prostate cancer death in a conservatively managed cohort
por: Fisher, G, et al.
Publicado: (2013)

Effects of oestrogens and anti-oestrogens on normal breast tissue from women bearing BRCA1 and BRCA2 mutations
por: Bramley, M, et al.
Publicado: (2006)

Predictive factors for skeletal complications in hormone-refractory prostate cancer patients with metastatic bone disease
por: Berruti, A, et al.
Publicado: (2005)

Docetaxel and epirubicin compared with docetaxel and prednisone in advanced castrate-resistant prostate cancer: a randomised phase II study
por: Petrioli, R, et al.
Publicado: (2011)

Treatment of local–regional prostate cancer detected by PSA screening: benefits and harms according to prognostic factors
por: Wever, E M, et al.
Publicado: (2013)

Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group study
por: Berney, D M, et al.
Publicado: (2009)

The New Œstrogens
por: Dodds, E. C.
Publicado: (1941)

Cannot write session to /tmp/vufind_sessions/sess_t3eh2l3n2l2030lc91orvmujj8